Literature DB >> 12920581

Solitary thyroid nodule as presenting symptom of Pendred syndrome caused by a novel splice-site mutation in intron 8 of the SLC26A4 gene.

Guy Massa1, Nele Jaenen, Sebastien Janssens de Varebeke, Nils Peeters, Wim Wuyts.   

Abstract

UNLABELLED: Thyroid nodules are a rare occurrence in children but represent an important clinical problem because of the possibility of malignancy. We report the case of a 4-year-old boy with sensorineural deafness, who presented with a painless mass in the right anterior cervical region. Cervical ultrasound demonstrated a solid nodule (1.4 x 2.5 x 1.7 cm) in the right thyroid lobe. Thyroid function tests revealed compensated hypothyroidism (free T4 1.0 ng/dl; TSH 57 mIU/l) with no detectable thyroid antibodies. A 99mTc thyroid scan showed a generalised slightly increased tracer retention (4.6%) with an enlarged right lobe, without distinct nodules. A fine-needle aspiration biopsy revealed normal follicular cells. The boy was treated with l-thyroxine which resulted in a complete clinical and sonographical disappearance of the nodule. A CT scan of temporal bones revealed a bilaterally enlarged vestibular aqueduct with Mondini malformation of the cochlea. The combination of all these symptoms suggested the diagnosis of Pendred syndrome (PDS), a disorder characterised by congenital sensorineural hearing loss and a variable degree of thyromegaly due to mutations in the SLC26A4/PDSgene. DNA analysis disclosed a so far unreported homozygous splice site mutation (1002-4 C>G) in intron 8 of the SLC26A4 gene confirming this diagnosis.
CONCLUSION: a solitary thyroid nodule may therefore be another presenting symptom of thyroid involvement in Pendred syndrome

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12920581     DOI: 10.1007/s00431-003-1281-0

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  17 in total

1.  Pendrin, the protein encoded by the Pendred syndrome gene (PDS), is an apical porter of iodide in the thyroid and is regulated by thyroglobulin in FRTL-5 cells.

Authors:  I E Royaux; K Suzuki; A Mori; R Katoh; L A Everett; L D Kohn; E D Green
Journal:  Endocrinology       Date:  2000-02       Impact factor: 4.736

2.  Radiological malformations of the ear in Pendred syndrome.

Authors:  P D Phelps; R A Coffey; R C Trembath; L M Luxon; A B Grossman; K E Britton; P Kendall-Taylor; J M Graham; B C Cadge; S G Stephens; M E Pembrey; W Reardon
Journal:  Clin Radiol       Date:  1998-04       Impact factor: 2.350

3.  Pendred syndrome, DFNB4, and PDS/SLC26A4 identification of eight novel mutations and possible genotype-phenotype correlations.

Authors:  C Campbell; R A Cucci; S Prasad; G E Green; J B Edeal; C E Galer; L P Karniski; V C Sheffield; R J Smith
Journal:  Hum Mutat       Date:  2001-05       Impact factor: 4.878

4.  Expression pattern of the mouse ortholog of the Pendred's syndrome gene (Pds) suggests a key role for pendrin in the inner ear.

Authors:  L A Everett; H Morsli; D K Wu; E D Green
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-17       Impact factor: 11.205

5.  The Pendred syndrome gene encodes a chloride-iodide transport protein.

Authors:  D A Scott; R Wang; T M Kreman; V C Sheffield; L P Karniski
Journal:  Nat Genet       Date:  1999-04       Impact factor: 38.330

6.  Fine-needle aspiration biopsy in the management of thyroid nodules in children and adolescents.

Authors:  A Al-Shaikh; B Ngan; A Daneman; D Daneman
Journal:  J Pediatr       Date:  2001-01       Impact factor: 4.406

7.  Pendred syndrome is caused by mutations in a putative sulphate transporter gene (PDS).

Authors:  L A Everett; B Glaser; J C Beck; J R Idol; A Buchs; M Heyman; F Adawi; E Hazani; E Nassir; A D Baxevanis; V C Sheffield; E D Green
Journal:  Nat Genet       Date:  1997-12       Impact factor: 38.330

8.  Pendred's syndrome.

Authors:  Y Kabakkaya; E Bakan; M R Yiğitoğlu; G Gökçe; M Doğan
Journal:  Ann Otol Rhinol Laryngol       Date:  1993-04       Impact factor: 1.547

9.  Two frequent missense mutations in Pendred syndrome.

Authors:  P Van Hauwe; L A Everett; P Coucke; D A Scott; M L Kraft; C Ris-Stalpers; C Bolder; B Otten; J J de Vijlder; N L Dietrich; A Ramesh; S C Srisailapathy; A Parving; C W Cremers; P J Willems; R J Smith; E D Green; G Van Camp
Journal:  Hum Mol Genet       Date:  1998-07       Impact factor: 6.150

10.  Molecular analysis of the PDS gene in Pendred syndrome.

Authors:  B Coyle; W Reardon; J A Herbrick; L C Tsui; E Gausden; J Lee; R Coffey; A Grueters; A Grossman4; P D Phelps; L Luxon; P Kendall-Taylor; S W Scherer; R C Trembath
Journal:  Hum Mol Genet       Date:  1998-07       Impact factor: 6.150

View more
  3 in total

1.  Association of SLC26A4 mutations with clinical features and thyroid function in deaf infants with enlarged vestibular aqueduct.

Authors:  Satoshi Iwasaki; Koji Tsukamoto; Shinichi Usami; Kiyoshi Misawa; Kunihiro Mizuta; Hiroyuki Mineta
Journal:  J Hum Genet       Date:  2006-08-19       Impact factor: 3.172

2.  Goiter and hearing impairment: A case of a male patient with Pendred syndrome.

Authors:  Er-Wei Hu; Li-Bin Liu; Ruo-Yu Jiang; Xiang-Hui He
Journal:  Oncol Lett       Date:  2014-08-19       Impact factor: 2.967

3.  A New Genetic Diagnostic for Enlarged Vestibular Aqueduct Based on Next-Generation Sequencing.

Authors:  Yalan Liu; Lili Wang; Yong Feng; Chufeng He; Deyuan Liu; Xinzhang Cai; Lu Jiang; Hongsheng Chen; Chang Liu; Hong Wu; Lingyun Mei
Journal:  PLoS One       Date:  2016-12-20       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.